Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stem Cell Innovations, Inc. (SCLL.OB) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Stem Cell Innovations, Inc.. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 351532.
Total stock buying since 2007: $0.
Total stock sales since 2007: $120,466.
Total stock option exercises since 2007: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 9,186,514 | $100,198 | 0 | $0 |
| 2007 | 0 | $0 | 1,713,486 | $20,268 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-03 | 0 | $0 | 44,633 | $580 | 0 | $0 |
| 2008-02 | 0 | $0 | 8,200,000 | $90,200 | 0 | $0 |
| 2008-01 | 0 | $0 | 941,881 | $9,418 | 0 | $0 |
| 2007-12 | 0 | $0 | 1,713,486 | $20,268 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-03-03 | Kelly James H (Chief Executive Officer) | Sale | 44,633 | .01 | 580 |
| 2008-02-29 | Kelly James H (Chief Executive Officer) | Sale | 8,200,000 | .01 | 90,200 |
| 2008-01-03 | Kelly James H (Chief Executive Officer) | Sale | 400,000 | .01 | 4,000 |
| 2008-01-02 | Kelly James H (Chief Executive Officer) | Sale | 541,881 | .01 | 5,418 |
| 2007-12-26 | Kelly James H (Chief Executive Officer) | Sale | 173,486 | .01 | 1,734 |
| 2007-12-19 | Kelly James H (Chief Executive Officer) | Sale | 180,000 | .01 | 1,979 |
| 2007-12-18 | Kelly James H (Chief Executive Officer) | Sale | 250,000 | .01 | 2,750 |
| 2007-12-17 | Kelly James H (Chief Executive Officer) | Sale | 155,000 | .01 | 1,705 |
| 2007-12-13 | Kelly James H (Chief Executive Officer) | Sale | 200,000 | .01 | 2,400 |
| 2007-12-12 | Kelly James H (Chief Executive Officer) | Sale | 115,000 | .01 | 1,380 |
| 2007-12-11 | Kelly James H (Chief Executive Officer) | Sale | 640,000 | .01 | 8,320 |
Insider trading activities including stock purchases, stock sales, and option exercises of SCLL.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stem Cell Innovations, Inc. (symbol SCLL.OB, CIK number 351532) see the Securities and Exchange Commission (SEC) website.